Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment

Blood Pressure

Volumn 19, Issue 4, 2010, Pages 240-248

  Journath, Gunilla ^a,b   Hellénius, Mai Lis ^a   Carlsson, Axel C ^c   Wndell, Per E ^c   Nilsson, Peter M ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Merck Sharp Dohme (Sweden)   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholesterol; Gender; Hypertension; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC HYPERTENSION;

AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 77955324679     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051003768247     Document Type: Article

References (42)

1. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple risk factor intervention trial research group. Arch Intern Med. 1992;152:56-64.
2. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
3. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004;25:484-491.
4. Whitworth JA. 2003 World Health Organization (Who)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
5. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-I. Arch Intern Med. 1998;158:981-988.
6. Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583-589.
7. Hall JA, Palmer RH, Orav EJ, Hargraves JL, Wright EA, Louis TA. Performance quality, gender, and professional role. A study of physicians and nonphysicians in 16 ambulatory care practices. Med Care. 1990;28:489-501.
8. Maheux B, Dufort F, Beland F, Jacques A, Levesque A. Female medical practitioners. More preventive and patient oriented? Med Care. 1990;28:87-92.
9. Rathore SS, Chen J, Wang Y, Radford MJ, Vaccarino V, Krumholz HM. Sex differences in cardiac catheterization: The role of physician gender. JAMA. 2001;286:2849-2856.
10. Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: A meta-analytic review. JAMA. 2002; 288:756-764.
11. Ewing GB, Selassie AW, Lopez CH, McCutcheon EP. Self-report of delivery of clinical preventive services by U.S. Physicians. Comparing specialty, gender, age, setting of practice, and area of practice. Am J Prev Med. 1999;17: 62-72.
12. Journath G, Hellenius ML, Manhem K, Kjellgren KI, Nilsson PM. Association of physician s sex with risk factor control in treated hypertensive patients from Swedish primary healthcare. J Hypertens. 2008;26:2050-2056.
13. Lurie N, Margolis KL, McGovern PG, Mink PJ, Slater JS. Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med. 1997; 12:34-43.
14. Kim C, McEwen LN, Gerzoff RB, Marrero DG, Mangione CM, Selby JV, et al. Is physician gender associated with the quality of diabetes care? Diabetes Care. 2005;28: 1594-1598.
15. Schmittdiel J, Grumbach K, Selby JV, Quesenberry CP, Jr. Effect of physician and patient gender concordance on patient satisfaction and preventive care practices. J Gen Intern Med. 2000;15:761-769.
16. The Swedish Council on Technology Assessment in Health Care. Moderately elevated blood pressure. Report Volumes 1-3. Stockholm: Swedish Council on Technology Assessment in Health Care; 2004.
17. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J. 2003;24:987-1003.
18. Daniel WD. Biostatistics: A foundation for analysis in the health sciences. 6th ed. New York: John Wiley & Sons; 1995. p. 295-341.
19. Montgomery D. Design and analysis of experiments. 3rd ed. New York: John Wiley & Sons, 1991. p. 63-79.
20. Berthold HK, Gouni-Berthold I, Bestehorn KP, Bohm M, Krone W. Physician gender is associated with the quality of type 2 diabetes care. J Intern Med. 2008;264:340-350.
21. Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. J Cardiovasc Risk. 2002;9: 67-76.
22. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: Insights from the INTERHEART study. Eur Heart J. 2008;29:932-940.
23. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28: 88-136.
24. Franklin SS, Gustin Wt, Wong ND, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
25. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol. 1987;59:91G-94G.
26. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA investigators. Ann Intern Med. 1997;126: 761-767.
27. Journath G, Hellenius ML, Petersson U, Theobald H, Nilsson PM. Sex differences in risk factor control of treated hypertensives: A national primary healthcare-based study in Sweden. Eur J Cardiovasc Prev Rehabil. 2008;15: 258-262.
28. Keyhani S, Scobie JV, Hebert PL, McLaughlin MA. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension. 2008;51:1149-1155.
29. Hedblad B, Nerbrand C, Ekesbo R, Johansson L, Midlov P, Brunkstedt I, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care. 2006;24: 224-230.
30. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
31. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339: 1957-1963.
32. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid lowering arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003;361:1149-1158.
33. Strazzullo P, Kerry SM, Barbato A, Versiero M, D E lia L, Cappuccio FP. Do statins reduce blood pressure? A metaanalysis of randomized, controlled trials. Hypertension. 2007;49:792-798.
34. Bardel A, Wallander MA, Svardsudd K. Factors associated with adherence to drug therapy: A population-based study. Eur J Clin Pharmacol 2007;63:307-314.
35. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165:1147-1152.
36. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483-492.
37. Bailey JE, Lee MD, Somes GW, Graham RL. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther. 1996;18:1252-1262.
38. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women s Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 2000;9: 506-515.
39. Abuful A, Gidron Y, Henkin Y. Physicians attitudes toward preventive therapy for coronary artery disease: Is there a gender bias? Clin Cardiol. 2005;28:389-393.
40. M osca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499-510.
41. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics-2007 update: A report from the American heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-171.
42. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290: 898-904.